GSH/pH-sensitive Förster resonance energy transfer nanoparticles for synergistic chemotherapy and chemodynamic therapy
Journal of Materials Chemistry B · 2025
DOI: 10.1039/d5tb00243e ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2025. Verfasst von Xiaodong Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Polymer Science and Engineering, School of Chemical Engineering, Hebei University of Technology, Tianjin 300130, China. xwqu@hebut.edu.c…. Hauptthemen laut MEDLINE: Doxorubicin, Nanoparticles, Glutathione, Drug Carriers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
This paper reports a GSH responsive polymer with aggregation induced emission (AIE) properties and Förster resonance energy transfer (FRET) effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Polymer Science and Engineering, School of Chemical Engineering, Hebei University of Technology, Tianjin 300130, China. xwqu@hebut.edu.cn.
Förderung
- Natural Science Foundation of Hebei Province
Zitieren
APA
Zheng, X., Cui, Y., Rong, J., Chen, S., Qu, X., & Hu, X. (2025). GSH/pH-sensitive Förster resonance energy transfer nanoparticles for synergistic chemotherapy and chemodynamic therapy. Journal of Materials Chemistry B. https://doi.org/10.1039/d5tb00243e
Vancouver
Zheng X, Cui Y, Rong J, Chen S, Qu X, Hu X. GSH/pH-sensitive Förster resonance energy transfer nanoparticles for synergistic chemotherapy and chemodynamic therapy. Journal of Materials Chemistry B. 2025. doi:10.1039/d5tb00243e
BibTeX
@article{Zheng2025,
author = {Zheng, Xiaodong and Cui, Yingjian and Rong, Jianxin and Chen, Shengli and Qu, Xiongwei and Hu, Xiuli},
title = {GSH/pH-sensitive Förster resonance energy transfer nanoparticles for synergistic chemotherapy and chemodynamic therapy},
journal = {Journal of Materials Chemistry B},
year = {2025},
doi = {10.1039/d5tb00243e}
}
EUVIMED